more

Merck & Co. (MRK)

(Delayed Data from NYSE)

$131.20 USD

+0.48 (0.37%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $131.20 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

Bottom 21% (198 out of 252)

Industry: Large Cap Pharmaceuticals

View All Zacks #1 Ranked Stocks

Better trading starts here.

Research for MRK

Annual Key Company Metrics
Quarterly Key Company Metrics

Revenue - Line of Business Segments	YR Estimate	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Sales: Cardiovascular: Adempas [$...		255	238	252	220	215
Sales: Neuroscience: Belsomra - U...		81	79	78	81	92
Sales: Neuroscience: Belsomra - I...		150	179	241	247	214
Sales: Animal Health: Livestock [...		3,337	3,300	3,295	2,939	2,784
Sales: Animal Health: Companion A...		2,288	2,250	2,273	1,764	1,609
Sales: Hospital Acute Care: Zerba...		218	169	-1	130	121
Sales: Cardiovascular: Alliance r...		367	341	342	281	204
Sales: Hospital Acute Care: Prevy...		605	428	370	281	165
Sales: Virology: Lagevrio [$M]		1,428	5,684	952	--	--
Sales: Hospital Acute Care: Dific...		302	263	175	--	--
Sales: Vaccines: Vaxneuvance [$M]		665	170	--	--	--
Segment revenues: Pharmaceutical ...		53,583	52,005	42,754	36,610	41,751
Other Revenues [$M]		907	1,728	382	182	521
Sales: Virology: Isentress [$M]		483	633	769	857	975
Sales: Diabetes: Janumet [$M]		1,177	1,700	1,964	1,971	2,041
Sales: Diabetes: Januvia [$M]		2,189	2,813	3,324	3,306	3,482
Sales: Hospital Acute Care: Noxaf...		213	238	259	329	662
Sales: Diabetes: Other Pharmaceut...		2,283	2,319	2,118	2,312	696
Sales: Hospital Acute Care: Prima...		213	239	259	251	273
Sales: Immunology: Remicade [$M]	--	187	207	299	330	411
Sales: Immunology: Simponi [$M]		710	706	825	838	830
Segment revenues: Animal health [...		5,625	5,550	5,568	4,703	4,393
Sales: Hospital Acute Care: Bridi...		1,842	1,685	1,532	1,198	1,131
Sales: Oncology: Keytruda [$M]		25,011	20,937	17,186	14,380	11,084
Sales: Alliance Revenue: Lynparza...		1,199	1,116	989	725	444
Sales: Alliance revenue: Lenvima ...		960	876	704	580	404
Sales: Oncology: Alliance revenue...		212	166	17	--	--
Sales: Vaccines: Gardasil [$M]		8,886	6,897	5,673	3,938	3,737
Sales: Vaccines: ProQuar/M-M-R II...		2,368	2,241	2,135	1,878	2,275
Sales: RotaTeq [$M]		769	783	807	797	791
Sales: Vaccines: Pneumovax [$M]		412	602	893	1,087	926
Sales: Vaccines: Vaqta [$M]		180	173	179	170	238
Total Vaccines [$M]		13,654	11,297	10,132	8,257	8,368
Revenue - Geographic Segments	YR Estimate	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Sales: Hospital Acute Care: Bridi...		1,156	922	762	583	533
Sales: Diabetes: Januvia - U.S. [...		1,151	1,248	1,404	1,470	1,724
Sales: Diabetes: Janumet - U.S. [...		223	355	367	477	589
Sales: Cardiovascular: Adempas - ...		255	238	252	220	215
Sales: Neuroscience: Belsomra [$M...		231	258	318	327	306
Sales: Animal Health: Livestock -...		700	710	667	612	582
Sales: Animal Health: Livestock -...		2,637	2,590	2,628	2,327	2,201
Sales: Animal Health: Companion A...		1,104	1,112	1,091	872	724
Sales: Animal Health: Companion A...		1,184	1,138	1,182	892	885
Sales: Vaccines: Vaqta - U.S. [$M...		119	95	100	103	130
Sales: Vaccines: Vaqta - Internat...		61	78	79	67	108
Sales: Hospital Acute Care: Zerba...		119	89	4	74	63
Sales: Hospital Acute Care: Zerba...		100	79	-5	56	58
Sales: Cardiovascular: Alliance r...		350	329	312	259	194
Sales: Cardiovascular: Alliance r...		16	12	30	22	10
Sales: Hospital Acute Care: Prevy...		264	188	153	119	84
Sales: Hospital Acute Care: Prevy...		341	240	218	162	81
Sales: Virology: Lagevrio - Inter...		1,418	4,161	320	--	--
Sales: Hospital Acute Care: Dific...		274	241	166	--	--
Sales: Hospital Acute Care: Dific...		28	22	10	--	--
Segment revenues: Pharmaceutical ...		26,539	24,989	20,401	18,010	--
Segment revenues: Pharmaceutical ...		27,044	27,016	22,353	18,600	--
Sales: Diabetes: Other pharmaceut...		688	693	841	984	--
Sales: Diabetes: Other pharmaceut...		1,596	1,628	1,275	1,328	--
Product sales: Other revenues - U...		137	395	266	71	--
Product sales: Other revenues - I...		770	1,333	116	111	--
Geographic Revenue: International...		31,635	32,077	26,279	21,930	--
Sales: Vaccines: Vaxneuvance - U....		561	163	--	--	--
Sales: Vaccines: Vaxneuvance - In...		103	7	--	--	--
Geographic Revenue: United States...		28,480	27,206	22,425	19,588	20,519
Sales: Virology: Isentress - Inte...		268	359	474	531	576
Sales: Diabetes: Janumet - Intern...		954	1,344	1,597	1,494	1,452
Sales: Diabetes: Januvia - Intern...		1,039	1,565	1,920	1,836	1,758
Sales: Hospital Acute Care: Prima...		211	238	258	248	271
Sales: Vaccines: ProQuar/M-M-R II...		531	518	506	500	592
Sales: Vaccines: Rotateq - Intern...		276	275	334	311	284
Sales: Hospital Acute Care: Noxaf...		32	51	60	42	282
Sales: Hospital Acute Care: Noxaf...		181	187	199	287	380
Sales: Primaxin - U.S. [$M]		1	1	2	2	2
Sales: Vaccines: ProQuad, M-M-R I...		1,837	1,724	1,629	1,378	1,683
Sales: Vaccines: RotaTeq - U.S. [...		493	508	473	486	506
Sales: Vaccines: Pneumovax - U.S....		127	346	547	727	679
Sales: Vaccines: Pneumovax - Inte...		285	256	346	359	247
Sales: Virology: Isentress - U.S....		215	274	294	326	398
Sales: Animal health - U.S. [$M]		1,804	1,822	1,758	1,484	1,306
Sales: Animal health - Internatio...		3,821	3,728	3,810	3,219	3,086
Sales: Hospital Acute Care: Bridi...		686	762	770	615	598
Sales: Oncology: Keytruda - U.S. ...		15,114	12,686	9,765	8,352	6,305
Sales: Oncology: Keytruda - Inter...		9,897	8,251	7,421	6,028	4,779
Sales: Oncology: Alliance revenue...		607	584	515	417	269
Sales: Oncology: Alliance revenue...		592	532	473	308	176
Sales: Oncology: Alliance revenue...		657	579	417	359	239
Sales: Oncology: Alliance revenue...		303	297	287	220	165
Sales: Oncology: Alliance revenue...		168	123	0	--	--
Sales: Oncology: Alliance revenue...		43	43	17	--	--
Sales: Gardasil - U.S. [$M]		2,083	2,065	1,881	1,755	1,831
Sales: Vaccines: Gardasil - Inter...		6,803	4,832	3,792	2,184	1,905

Revenue - Line of Business Segments	Qtr Estimate	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023
Sales: Cardiovascular: Adempas [$...		70	66	65	65	59
Sales: Neuroscience: Belsomra - U...		--	21	23	21	16
Sales: Neuroscience: Belsomra - I...		--	33	35	42	40
Sales: Animal Health: Livestock [...		850	808	874	807	849
Sales: Animal Health: Companion A...		661	470	526	649	642
Sales: Hospital Acute Care: Zerba...		56	61	53	54	50
Sales: Cardiovascular: Alliance r...		--	108	92	68	99
Sales: Hospital Acute Care: Prevy...		174	175	157	143	129
Sales: Virology: Lagevrio [$M]		350	193	640	203	392
Sales: Hospital Acute Care: Dific...		73	87	74	76	65
Sales: Vaccines: Vaxneuvance [$M]		219	176	214	168	106
Segment revenues: Pharmaceutical ...		14,006	13,141	14,263	13,457	12,721
Other Revenues [$M]		258	211	299	122	275
Sales: Virology: Isentress [$M]		111	105	119	136	123
Sales: Diabetes: Janumet [$M]		251	240	255	354	329
Sales: Diabetes: Januvia [$M]		419	547	581	511	551
Sales: Hospital Acute Care: Noxaf...		56	46	51	55	60
Sales: Diabetes: Other Pharmaceut...		--	595	549	553	584
Sales: Hospital Acute Care: Prima...		--	39	41	53	80
Sales: Immunology: Remicade [$M]		39	43	45	48	51
Sales: Immunology: Simponi [$M]		184	171	179	180	180
Segment revenues: Animal health [...		1,511	1,278	1,400	1,456	1,491
Sales: Hospital Acute Care: Bridi...		440	429	424	502	487
Sales: Oncology: Keytruda [$M]		6,947	6,608	6,338	6,271	5,795
Sales: Alliance Revenue: Lynparza...		292	315	299	310	275
Sales: Alliance revenue: Lenvima ...		255	226	260	242	232
Sales: Oncology: Alliance revenue...		--	70	52	47	43
Sales: Vaccines: Gardasil [$M]		2,249	1,871	2,585	2,458	1,972
Sales: Vaccines: ProQuar/M-M-R II...		570	545	713	582	528
Sales: RotaTeq [$M]		216	185	156	131	297
Sales: Vaccines: Pneumovax [$M]		61	85	140	92	96
Sales: Vaccines: Vaqta [$M]		--	29	69	42	40
Total Vaccines [$M]		3,424	2,962	4,002	3,557	3,133
Revenue - Geographic Segments	Qtr Estimate	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023
Sales: Hospital Acute Care: Bridi...		329	315	265	299	276
Sales: Diabetes: Januvia - U.S. [...		183	309	328	243	271
Sales: Diabetes: Janumet - U.S. [...		39	41	43	82	56
Sales: Cardiovascular: Adempas - ...		70	66	65	65	59
Sales: Neuroscience: Belsomra [$M...		46	54	58	63	56
Sales: Animal Health: Livestock -...		166	158	205	165	174
Sales: Animal Health: Livestock -...		683	649	669	643	676
Sales: Animal Health: Companion A...		308	229	257	310	308
Sales: Animal Health: Companion A...		354	242	269	339	334
Sales: Vaccines: Vaqta - U.S. [$M...		--	28	32	29	30
Sales: Vaccines: Vaqta - Internat...		--	1	37	13	10
Sales: Hospital Acute Care: Zerba...		33	33	29	30	27
Sales: Hospital Acute Care: Zerba...		23	28	24	24	23
Sales: Cardiovascular: Alliance r...		98	102	96	70	83
Sales: Cardiovascular: Alliance r...		8	6	-4	-2	16
Sales: Hospital Acute Care: Prevy...		74	78	70	61	54
Sales: Hospital Acute Care: Prevy...		100	98	87	82	75
Sales: Virology: Lagevrio - Inter...		305	183	640	201	394
Sales: Hospital Acute Care: Dific...		68	75	69	68	62
Sales: Hospital Acute Care: Dific...		5	12	5	8	3
Segment revenues: Pharmaceutical ...		6,936	6,698	7,153	6,570	6,117
Segment revenues: Pharmaceutical ...		7,070	6,443	7,110	6,887	6,604
Sales: Diabetes: Other pharmaceut...		157	144	197	171	172
Sales: Diabetes: Other pharmaceut...		419	450	353	382	414
Product sales: Other revenues - U...		68	3	100	-27	60
Product sales: Other revenues - I...		190	208	199	149	214
Geographic Revenue: International...		8,297	7,542	8,247	8,018	7,828
Sales: Vaccines: Vaxneuvance - U....		161	138	182	147	94
Sales: Vaccines: Vaxneuvance - In...		58	38	33	20	13
Geographic Revenue: United States...		7,478	7,088	7,715	7,018	6,659
Sales: Virology: Isentress - Inte...		61	56	61	80	71
Sales: Diabetes: Janumet - Intern...		212	198	211	272	272
Sales: Diabetes: Januvia - Intern...		236	239	252	267	280
Sales: Hospital Acute Care: Prima...		--	39	41	56	76
Sales: Vaccines: ProQuar/M-M-R II...		133	143	146	135	107
Sales: Vaccines: Rotateq - Intern...		67	73	48	37	180
Sales: Hospital Acute Care: Noxaf...		--	4	4	11	14
Sales: Hospital Acute Care: Noxaf...		--	43	47	45	46
Sales: Primaxin - U.S. [$M]		--	0	0	-2	4
Sales: Vaccines: ProQuad, M-M-R I...		438	402	567	447	421
Sales: Vaccines: RotaTeq - U.S. [...		149	112	108	93	180
Sales: Vaccines: Pneumovax - U.S....		6	22	42	23	40
Sales: Vaccines: Pneumovax - Inte...		--	62	98	69	56
Sales: Virology: Isentress - U.S....		50	50	58	56	52
Sales: Animal health - U.S. [$M]		474	387	462	475	482
Sales: Animal health - Internatio...		1,037	891	938	982	1,010
Sales: Hospital Acute Care: Bridi...		111	113	159	203	40
Sales: Oncology: Keytruda - U.S. ...		4,119	3,972	3,795	3,863	3,485
Sales: Oncology: Keytruda - Inter...		2,828	2,636	2,543	2,408	2,310
Sales: Oncology: Alliance revenue...		135	168	153	144	142
Sales: Oncology: Alliance revenue...		157	147	146	166	133
Sales: Oncology: Alliance revenue...		173	181	160	163	153
Sales: Oncology: Alliance revenue...		82	45	100	79	79
Sales: Oncology: Alliance revenue...		58	60	43	36	30
Sales: Oncology: Alliance revenue...		12	10	10	11	12
Sales: Gardasil - U.S. [$M]		--	365	838	464	416
Sales: Vaccines: Gardasil - Inter...		1,761	1,506	1,746	1,994	1,556

Member Sign In

Member Sign In

Services Overview

Investor Services

Other Services

Trading Services

Innovators